A congressman said "evidence of fraud appears to be present" as a federal watchdog issued subpoenas related to Maryland's Obamacare exchange.» Read More
Electronic cigarettes, promoted as a healthier alternative to tobacco, are getting powerful new backers: big tobacco firms. NYT reports.
Valeant said it plans to launch an exchange offer to Allergan shareholders this week, soliciting proxies to call for a meeting to discuss its offer.
The Food and Drug Administration is preparing voluntary guidelines for the food industry to lower sodium levels to address health concerns.
As the global population ages, some see investment opportunities in somewhat ghoulish bets the rates of cancer and other illnesses will rise.
The United States health-care system has again come in last in a comparison of other first-world countries, despite vastly outspending those nations.
Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.
A new medical device can automatically control blood sugar levels in diabetics, freeing patients from testing themselves. NBC News reports.
The government is contacting hundreds of thousands of people with subsidized health insurance to resolve questions about their eligibility. The NYT reports.
WebMD will launch Healthy Target, a service that collects data from wearables to offer up personalized health content and tips.
Some Americans who've enrolled in an Obamacare exchange plan with a government subsidy could find themselves on the hook to Uncle Sam next spring.
In-network health providers charge insured patients a wide range of prices for the same services in different cities—and even in the same city.
Medtronic is buying Covidien in a $42.9 billion agreement that could increase concerns about the rush of U.S. companies striking deals to cut their tax bills.
Many of the world's biggest drugmakers will gather starting Friday in San Francisco for the American Diabetes Association's annual meeting. Here's what investors need to know.
This month, the full moon falls on Friday the 13th. Freaky? Nah, probably not.
Data released shows weaker health care spending in the US.
If the Supreme Court rules in favor of Halliburton and against shareholders, then other businesses will gain, as well.
Orexigen Therapeutics shares fell 15 percent after the FDA delayed its decision on the drug pending post-marketing safety monitoring requirements.
Achillion's been a takeover target for years. But Merck's acquisition of Idenix may mean Achillion's time has come.
Baupost Group appears to have made a nearly $1 billion off of Merck's deal to buy Idenix.
A person who found personal information of 413 Obamacare enrollees in an abandoned backpack in Connecticut first contacted a top GOP legislator.
Get the best of CNBC in your inbox